Hello, I am Janey Willis, ISN Guide to Diabetes. Type 1 Diabetes is an autoimmune disease, and Type 2 Diabetes is caused by risk factors such as lifestyle, ethnicity, age, and pregnancy. The majority of diabetics have Type 2. See Disclaimer.
|Clinical Trials for Diabetes||Research on Diabetes|
Clinical trials give patients the opportunity to try treatments that are still in development. Ask your diabetic specialist if there are any clinical trials suitable for you. (Also see Autoimmune Diseases and Overview of Diabetes)
Immunotherapy for Type 1 diabetes. Stem cell therapies achieved thus this far the most promising results, while immune ablation and standard immunosuppressants did not maintain the premises of preclinical results. PubMed, J Endocrinol Invest, 03/04/2017.
Hope for Reversing Type 2 Diabetes. New research raises the tantalizing possibility that drastic changes in diet may reverse Type 2 diabetes in some people. New York Times, 04/18/2016.
Diabetes could be revolutionised by new skin patch that tests blood sugar AND delivers drugs when needed. A patch that measures sugar in a diabetic's sweat could spell an end to painful insulin injections and finger jab tests. Mail Online, 03/21/2016.
The case for an autoimmune aetiology of type 1 diabetes (T1D). Further data in support of the autoimmune basis of T1D from many fields, including genetics, experimental therapies and immunology, is discussed. PubMed, Clin Exp Immunol. 2016 Jan;183(1):8-15. (Also see B Cells and T Cells)
Artificial pancreas provides better real-world control of type 1 diabetes. A system that combines frequent blood sugar measurements with software that varies the rate at which insulin is pumped into the body can significantly improve glucose control in type 1 diabetics. Reuters, 09/17/2015.
Polyglandular autoimmunity in autoimmune thyroid disease (AITD) behaves differently from polyglandular autoimmunity in type 1 diabetes. AITD shows clustering of gastric autoimmunity with celiac and adrenal autoimmunity, which is consistent with the proposed entity of the autoimmune polyglandular syndrome type 2. J. Wiebolt. (Also see Thyroid Disease)
SCLERO.ORG is the world's leading nonprofit for trustworthy research, support, education and awareness for scleroderma and related illnesses.
We are a service of the nonprofit International Scleroderma Network (ISN), which is a 501(c)(3) U.S.-based public charitable foundation, established in 2002. Meet Our Team, or Volunteer. Donations may also be mailed to: